- Acumen Powered by Robins Kaplan LLP®
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 17, 2024Emily Tremblay Named IP Rising Star by Euromoney in 2024 Women in Business Law Awards
-
June 17, 2024Three Robins Kaplan Partners Named BTI Client Service All-Stars
-
June 13, 2024Brendan Johnson Named South Dakota Trial Lawyer of The Year
-
June 27, 2024Sex Abuse Litigation
-
June 10-11, 20242024 Probate and Trust Law Section Conference
-
June 11, 2024FBA 2024 Federal Practice Seminar
-
June 2024Robins Kaplan Secures Landmark $7.75 Million Verdict in Aerosol Duster Misuse Case
-
June 2024To Seize or Not to Seize: Campus Protests and Police Uses of Force
-
June 2024Communicating Your Estate Plan: A Helpful Tool, Not a Fix-All
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Robins Kaplan LLP Attorney Holly Dolejsi Appointed to Plaintiffs’ Steering Committee for the Invokana Multidistrict Litigation
January 30, 2017
Minneapolis, MN—January 30, 2017—Judge Brian R. Martinotti of the District of New Jersey entered an order on Jan. 24 appointing Robins Kaplan LLP® associate Holly Dolejsi to the Plaintiffs’ Steering Committee for the Invokana multidistrict litigation.
Consolidated by the Judicial Panel on Multidistrict Litigation in December 2016, the Invokana cases involve claims that Invokana, a drug used to treat Type 2 diabetes, has been linked to diabetic ketoacidosis, a serious condition characterized by high levels of acid in the blood. Untreated, it can lead to coma or death. Symptoms that may indicate the onset of ketoacidosis include nausea, vomiting, abdominal pain, tiredness, and trouble breathing. Ketoacidosis may be present, even if a patient’s blood glucose levels are not very high.
What is Invokana?
Invokana is in a class of drugs called sodium-glucose cotransporter-2 inhibitors, which are used to treat Type 2 diabetes. In December 2015, the U.S. Food and Drug Administration required the makers of Invokana and other SGLT2 inhibitors to warn of the risk of ketoacidosis on their labels. The FDA’s review of reports of adverse events of ketoacidosis associated with the drugs noted that all patients required hospitalization or emergency treatment. To date, more than 100 Invokana cases are pending in the MDL, with more expected to be filed in the coming months.
Learn more about Invokana
If you or someone you know have developed diabetic ketoacidosis while taking Invokana, you may have an Invokana claim.
At Robins Kaplan LLP, we investigate potential claims on behalf of Invokana patients to see if they may have an Invokana case. Our firm includes attorneys experienced in pharmaceutical lawsuits like Invokana. We are careful listeners and your story is important to us. Our on-staff medical advisors are available to answer your questions and listen to your concerns as you determine what to do next.
For a free case evaluation, please call 1.800.553.9910 (toll-free). Our legal nurse consultants are standing by.
Related Publications
In Conversation with Tara Sutton, Head of The Mass Tort Practice at Robins Kaplan
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.